Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retroperitoneal sarcomas.

Barry W Feig1

  • 1Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA. bwfeig@mdanderson.org

Surgical Oncology Clinics of North America
|August 15, 2003
PubMed
Summary

Retroperitoneal sarcomas are rare tumors. Complete surgical removal is the main treatment, while adjuvant therapy is still under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.

Nature cancer·2024
Same author

Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership.

Annals of surgical oncology·2023
Same author

Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.

Annals of surgical oncology·2022
Same author

Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.

Annals of surgical oncology·2022
Same author

Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases.

Annals of surgical oncology·2022
Same author

Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients.

Annals of surgical oncology·2022

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiology

Background:

  • Retroperitoneal sarcomas are uncommon and diverse tumors.
  • Diagnosis involves medical history, physical exam, and imaging.
  • Complete surgical resection is the standard primary treatment.

Purpose of the Study:

  • To outline the diagnostic and treatment approach for retroperitoneal sarcomas.
  • To clarify the current role of adjuvant therapies.

Main Methods:

  • Helical CT of the abdomen and pelvis is standard.
  • Magnetic Resonance Imaging (MRI) and preoperative tissue sampling are used selectively.
  • Complete surgical resection with a margin of healthy tissue is emphasized.

Main Results:

  • Surgical resection is the primary therapeutic strategy.
  • The utility of adjuvant therapy is not yet established and is considered investigational.

Conclusions:

  • Accurate diagnosis relies on a combination of clinical evaluation and advanced imaging.
  • Surgical expertise is crucial for achieving complete tumor removal.
  • Adjuvant therapies should currently be limited to clinical trials.

Related Experiment Videos